pubmed-article:2406254 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:2406254 | lifeskim:mentions | umls-concept:C0014834 | lld:lifeskim |
pubmed-article:2406254 | lifeskim:mentions | umls-concept:C0205145 | lld:lifeskim |
pubmed-article:2406254 | lifeskim:mentions | umls-concept:C1330957 | lld:lifeskim |
pubmed-article:2406254 | lifeskim:mentions | umls-concept:C2936473 | lld:lifeskim |
pubmed-article:2406254 | lifeskim:mentions | umls-concept:C1519249 | lld:lifeskim |
pubmed-article:2406254 | lifeskim:mentions | umls-concept:C1254042 | lld:lifeskim |
pubmed-article:2406254 | lifeskim:mentions | umls-concept:C0596311 | lld:lifeskim |
pubmed-article:2406254 | lifeskim:mentions | umls-concept:C0142292 | lld:lifeskim |
pubmed-article:2406254 | lifeskim:mentions | umls-concept:C1709694 | lld:lifeskim |
pubmed-article:2406254 | lifeskim:mentions | umls-concept:C1552848 | lld:lifeskim |
pubmed-article:2406254 | lifeskim:mentions | umls-concept:C1515655 | lld:lifeskim |
pubmed-article:2406254 | lifeskim:mentions | umls-concept:C1523987 | lld:lifeskim |
pubmed-article:2406254 | lifeskim:mentions | umls-concept:C1514873 | lld:lifeskim |
pubmed-article:2406254 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:2406254 | pubmed:dateCreated | 1990-3-23 | lld:pubmed |
pubmed-article:2406254 | pubmed:abstractText | Comparative analyses of a number of secretory proteins processed by eukaryotic and prokaryotic signal peptidases have identified a strongly conserved feature regarding the residues positioned -3 and -1 relative to the cleavage site. These 2 residues of the signal peptide are thought to constitute a recognition site for the processing enzyme and are usually amino acids with small, neutral side chains. It was shown previously that the substitution of aspartic acid for alanine at -3 of the Escherichia coli maltose-binding protein (MBP) signal peptide blocked maturation by signal peptidase I but had no noticeable effect or MBP translocation across the cytoplasmic membrane of its biological activity. This identified an excellent system in which to undertake a detailed investigation of the structural requirements and limitations for the cleavage site. In vitro mutagenesis was used to generate 14 different amino acid substitutions at -3 and 13 different amino acid substitutions at -1 of the MBP signal peptide. The maturation of the mutant precursor species expressed in vivo was examined. Overall, the results obtained agreed fairly well with statistically derived models of signal peptidase I specificity, except that cysteine was found to permit efficient processing when present at either -3 and -1, and threonine at -1 resulted in inefficient processing. Interestingly, it was found that substitutions at -1 which blocked processing at the normal cleavage site redirected processing, with varying efficiencies, to an alternate site in the signal peptide represented by the Ala-X-Ala sequence at positions -5 to -3. The substitution of aspartic acid for alanine at -5 blocked processing at this alternate site but not the normal site. The amino acids occupying the -5 and -3 positions in many other prokaryotic signal peptides also have the potential for constituting alternate processing sites. This appears to represent another example of redundant information contained within the signal peptide. | lld:pubmed |
pubmed-article:2406254 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2406254 | pubmed:language | eng | lld:pubmed |
pubmed-article:2406254 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2406254 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:2406254 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2406254 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2406254 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2406254 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2406254 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2406254 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2406254 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2406254 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2406254 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2406254 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2406254 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2406254 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2406254 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2406254 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:2406254 | pubmed:month | Feb | lld:pubmed |
pubmed-article:2406254 | pubmed:issn | 0021-9258 | lld:pubmed |
pubmed-article:2406254 | pubmed:author | pubmed-author:KlapperD GDG | lld:pubmed |
pubmed-article:2406254 | pubmed:author | pubmed-author:BassfordP... | lld:pubmed |
pubmed-article:2406254 | pubmed:author | pubmed-author:FikesJ DJD | lld:pubmed |
pubmed-article:2406254 | pubmed:author | pubmed-author:Barkocy-Galla... | lld:pubmed |
pubmed-article:2406254 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:2406254 | pubmed:day | 25 | lld:pubmed |
pubmed-article:2406254 | pubmed:volume | 265 | lld:pubmed |
pubmed-article:2406254 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:2406254 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:2406254 | pubmed:pagination | 3417-23 | lld:pubmed |
pubmed-article:2406254 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:2406254 | pubmed:meshHeading | pubmed-meshheading:2406254-... | lld:pubmed |
pubmed-article:2406254 | pubmed:meshHeading | pubmed-meshheading:2406254-... | lld:pubmed |
pubmed-article:2406254 | pubmed:meshHeading | pubmed-meshheading:2406254-... | lld:pubmed |
pubmed-article:2406254 | pubmed:meshHeading | pubmed-meshheading:2406254-... | lld:pubmed |
pubmed-article:2406254 | pubmed:meshHeading | pubmed-meshheading:2406254-... | lld:pubmed |
pubmed-article:2406254 | pubmed:meshHeading | pubmed-meshheading:2406254-... | lld:pubmed |
pubmed-article:2406254 | pubmed:meshHeading | pubmed-meshheading:2406254-... | lld:pubmed |
pubmed-article:2406254 | pubmed:meshHeading | pubmed-meshheading:2406254-... | lld:pubmed |
pubmed-article:2406254 | pubmed:meshHeading | pubmed-meshheading:2406254-... | lld:pubmed |
pubmed-article:2406254 | pubmed:meshHeading | pubmed-meshheading:2406254-... | lld:pubmed |
pubmed-article:2406254 | pubmed:meshHeading | pubmed-meshheading:2406254-... | lld:pubmed |
pubmed-article:2406254 | pubmed:meshHeading | pubmed-meshheading:2406254-... | lld:pubmed |
pubmed-article:2406254 | pubmed:meshHeading | pubmed-meshheading:2406254-... | lld:pubmed |
pubmed-article:2406254 | pubmed:meshHeading | pubmed-meshheading:2406254-... | lld:pubmed |
pubmed-article:2406254 | pubmed:meshHeading | pubmed-meshheading:2406254-... | lld:pubmed |
pubmed-article:2406254 | pubmed:meshHeading | pubmed-meshheading:2406254-... | lld:pubmed |
pubmed-article:2406254 | pubmed:meshHeading | pubmed-meshheading:2406254-... | lld:pubmed |
pubmed-article:2406254 | pubmed:year | 1990 | lld:pubmed |
pubmed-article:2406254 | pubmed:articleTitle | Maturation of Escherichia coli maltose-binding protein by signal peptidase I in vivo. Sequence requirements for efficient processing and demonstration of an alternate cleavage site. | lld:pubmed |
pubmed-article:2406254 | pubmed:affiliation | Department of Microbiology and Immunology, School of Medicine, University of North Carolina, Chapel Hill 27599-7290. | lld:pubmed |
pubmed-article:2406254 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:2406254 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2406254 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2406254 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2406254 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2406254 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2406254 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2406254 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2406254 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2406254 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2406254 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2406254 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2406254 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2406254 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2406254 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2406254 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2406254 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2406254 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2406254 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2406254 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2406254 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2406254 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2406254 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2406254 | lld:pubmed |